Outcomes and Tolerability of Early Mammalian Target of Rapamycin Inhibitor Initiation for Renal Sparing in Heart Transplant Recipients
In our experience, early mTORi initiation was associated with renal benefits in HTRs when compared to SOC. Conversion to mTORi allowed for lower tacrolimus levels without an increased risk for rejection or DSAs and was associated with less cardiac allograft vasculopathy at 24 months.
Authors
- Patricia P. Chang
- Christina Teeter Doligalski
- Ann C. Marcotte
- Mirnela Byku (ORCID: https://orcid.org/0000-0002-4541-5053)
- Rachel Rikard (ORCID: https://orcid.org/0000-0003-0670-6998)
- C. William Castor
- Margeaux Meilhac
Institutions
- University of North Carolina at Chapel Hill (US)
- University of North Carolina Health Care (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1111/ctr.70364
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00